254 related articles for article (PubMed ID: 9002763)
1. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Bombardieri E; Chiti A; Crippa F; Seregni E; Cataldo I; Maffioli L; Soresi E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):104-7. PubMed ID: 9002763
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Bombardieri E; Crippa F; Cataldo I; Chiti A; Seregni E; Soresi E; Boffi R; Invernizzi G; Buraggi GL
Eur J Cancer; 1995; 31A(2):184-8. PubMed ID: 7718323
[TBL] [Abstract][Full Text] [Related]
3. 111In-octreotide scintigraphy in small cell lung cancer.
Semprebene A; Ferraironi A; Franciotti G; Venturo I; Giunta S; Lopez M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):108-10. PubMed ID: 9002764
[TBL] [Abstract][Full Text] [Related]
4. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
5. Clinical diagnostic application of 111In-DTPA-octreotide scintigraphy in small cell lung cancer.
Vaccarili M; Lococo A; Fabiani F; Staffilano A
Tumori; 2000; 86(3):224-8. PubMed ID: 10939603
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor imaging in small cell lung cancer.
Berenger N; Moretti JL; Boaziz C; Vigneron N; Morere JF; Breau JL
Eur J Cancer; 1996 Jul; 32A(8):1429-31. PubMed ID: 8869110
[TBL] [Abstract][Full Text] [Related]
7. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer.
Soresi E; Bombardieri E; Chiti A; Boffi R; Invernizzi G; Crippa F; Maffioli L
Tumori; 1995; 81(2):125-7. PubMed ID: 7778214
[TBL] [Abstract][Full Text] [Related]
8. In-111 octreotide imaging in staging of small cell lung cancer.
Hochstenbag MM; Heidendal GA; Wouters EF; ten Velde GP
Clin Nucl Med; 1997 Dec; 22(12):811-6. PubMed ID: 9408640
[TBL] [Abstract][Full Text] [Related]
9. Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer.
Soresi E; Invernizzi G; Boffi R; Possa M; Bombardieri E; Ciavarella GP; Liuzzi A
Lung Cancer; 1997 Jul; 17(2-3):231-8. PubMed ID: 9237158
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
Reisinger I; Bohuslavitzki KH; Brenner W; Braune S; Dittrich I; Geide A; Kettner B; Otto HJ; Schmidt S; Munz DL
J Nucl Med; 1998 Feb; 39(2):224-7. PubMed ID: 9476922
[TBL] [Abstract][Full Text] [Related]
11. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
12. 111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer.
Crippa F; Bombardieri E; Chiti A; Soresi E; Boffi R; Buraggi GL
J Nucl Biol Med (1991); 1994 Dec; 38(4):576-8. PubMed ID: 7786920
[TBL] [Abstract][Full Text] [Related]
13. The value of octreotide scintigraphy in patients with lung cancer.
Kwekkeboom DJ; Kho GS; Lamberts SW; Reubi JC; Laissue JA; Krenning EP
Eur J Nucl Med; 1994 Oct; 21(10):1106-13. PubMed ID: 7828621
[TBL] [Abstract][Full Text] [Related]
14. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer.
Leitha T; Meghdadi S; Studnicka M; Wolzt M; Marosi C; Angelberger P; Neumann M; Schlick W; Kletter K; Dudczak R
J Nucl Med; 1993 Sep; 34(9):1397-402. PubMed ID: 8394882
[TBL] [Abstract][Full Text] [Related]
15. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E
Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
[TBL] [Abstract][Full Text] [Related]
16. Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Angusti T; Masaneo I; Maggi G; Bisi G
J Cardiovasc Surg (Torino); 1997 Jun; 38(3):313-5. PubMed ID: 9219485
[TBL] [Abstract][Full Text] [Related]
17. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
[TBL] [Abstract][Full Text] [Related]
18. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
Bernard BF; Krenning EP; Breeman WA; Rolleman EJ; Bakker WH; Visser TJ; Mäcke H; de Jong M
J Nucl Med; 1997 Dec; 38(12):1929-33. PubMed ID: 9430472
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
[TBL] [Abstract][Full Text] [Related]
20. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
